
INSP Stock Forecast & Price Target
INSP Analyst Ratings
Bulls say
Inspire Medical Systems is a promising company with a unique neurostimulation technology that provides a safe and effective treatment for obstructive sleep apnea. The company has recently commercialized its Inspire V system, which eliminates the need for a pressure sensing lead, and has a strong strategy in place to increase sales and awareness of its product. Challenges such as reimbursement changes and potential competition in the market may impact the company's growth in the near term, but the long-term potential and a large total addressable market make this a solid investment opportunity.
Bears say
Inspire Medical Systems is facing challenges in the evolving reimbursement landscape and has lowered its 2026 revenue guidance by 4-10% due to uncertainty around coding and physician reimbursement rates. There is a risk that the RUC process could result in a lower overall payment for a new CPT code, and the company's reliance on the existing code may lead to potential frictions with payers. While the company maintains a positive outlook on its operating margin and EPS, the uncertainty around physician reimbursement rates may continue to impact revenue growth and profitability in the near term.
This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.
INSP Analyst Forecast & Price Prediction
Start investing in INSP
Order type
Buy in
Order amount
Est. shares
0 shares